de Bruijn HW - Search Results

1

Cell biological markers of drug resistance in ovarian carcinoma.

van der Zee AG, Hollema HH, de Bruijn HW, Willemse PH, Boonstra H, Mulder NH, Aalders JG, de Vries EG. van der Zee AG, et al. Among authors: de vries eg, de bruijn hw. Gynecol Oncol. 1995 Aug;58(2):165-78. doi: 10.1006/gyno.1995.1205. Gynecol Oncol. 1995. PMID: 7622101 Review.

2

Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations.

Duk JM, de Bruijn HW, Groenier KH, Hollema H, ten Hoor KA, Krans M, Aalders JG. Duk JM, et al. Among authors: de bruijn hw. Gynecol Oncol. 1990 Nov;39(2):186-94. doi: 10.1016/0090-8258(90)90430-s. Gynecol Oncol. 1990. PMID: 2227594

3

Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.

Aalders JG, de Bruijn HW, Oosterhuis JW, Duk JM. Aalders JG, et al. Among authors: de bruijn hw. Gynecol Oncol. 1990 Jan;36(1):110-2. doi: 10.1016/0090-8258(90)90119-6. Gynecol Oncol. 1990. PMID: 2295441 No abstract available.

4

Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva.

van der Sijde R, de Bruijn HW, Krans M, Bouma J, Aalders JG. van der Sijde R, et al. Among authors: de bruijn hw. Gynecol Oncol. 1989 Nov;35(2):227-32. doi: 10.1016/0090-8258(89)90049-8. Gynecol Oncol. 1989. PMID: 2807015

5

Effect of low-dose oral etoposide on serum CA-125 in patients with advanced epithelial ovarian cancer.

de Jong RS, Hofstra LS, Willemse PH, de Bruijn HW, de Vries EG, Boonstra H, Mulder NH. de Jong RS, et al. Among authors: de vries eg, de bruijn hw. Gynecol Oncol. 1997 Aug;66(2):197-201. doi: 10.1006/gyno.1997.4760. Gynecol Oncol. 1997. PMID: 9264562 Clinical Trial.

6

Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.

Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, van der Zee AG. Engelen MJ, et al. Among authors: de bruijn hw. Gynecol Oncol. 2000 Jul;78(1):16-20. doi: 10.1006/gyno.2000.5811. Gynecol Oncol. 2000. PMID: 10873403

7

Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment.

Pras E, Willemse PH, Canrinus AA, de Bruijn HW, Sluiter WJ, ten Hoor KA, Aalders JG, Szabo BG, de Vries EG. Pras E, et al. Among authors: de bruijn hw. Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):23-32. doi: 10.1016/s0360-3016(01)01805-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 11777619

8

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.

Biesma B, Willemse PH, Mulder NH, Verschueren RC, Kema IP, de Bruijn HW, Postmus PE, Sleijfer DT, de Vries EG. Biesma B, et al. Among authors: de vries eg, de bruijn hw. Br J Cancer. 1992 Nov;66(5):850-5. doi: 10.1038/bjc.1992.372. Br J Cancer. 1992. PMID: 1384643 Free PMC article. Clinical Trial.

9

Endodermal sinus tumor of the ovary during pregnancy: a case report.

van der Zee AG, de Bruijn HW, Bouma J, Aalders JG, Oosterhuis JW, de Vries EG. van der Zee AG, et al. Among authors: de vries eg, de bruijn hw. Am J Obstet Gynecol. 1991 Feb;164(2):504-6. doi: 10.1016/s0002-9378(11)80009-8. Am J Obstet Gynecol. 1991. PMID: 1704183

10

Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.

Duk JM, Aalders JG, Fleuren GJ, Krans M, De Bruijn HW. Duk JM, et al. Among authors: de bruijn hw. Obstet Gynecol. 1989 Apr;73(4):661-8. Obstet Gynecol. 1989. PMID: 2648225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters